Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHELLE RENEE DREILING

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1083342935
CMS profile
11517977
Location
HUTCHINSON, KS

General Payments · PY2023–2024

$918.53

  • Reported across 43 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$738.85

38 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $738.85 38

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $268.91 3
Novo Nordisk AS $141.98 12
Amgen Inc. $131.98 10
Janssen Pharmaceuticals, Inc $58.25 4
PFIZER INC. $44.26 3
Sumitomo Pharma America, Inc. $31.14 2
Exact Sciences Corporation $28.46 2
Ardelyx, Inc. $19.35 1
Takeda Pharmaceuticals U.S.A., Inc. $14.52 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2023 $179.68 5
PY2024 $738.85 38

Payment records · PY2024 (38)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $9.03 04/23/2024 Food and Beverage Undisputed 01/23/2026 1117241913 CMS
Amgen Inc. $13.07 05/21/2024 Food and Beverage Undisputed 01/23/2026 1117241915 CMS
Amgen Inc. $15.37 06/10/2024 Food and Beverage Undisputed 01/23/2026 1117544644 CMS
Amgen Inc. $12.43 07/18/2024 Food and Beverage Undisputed 01/23/2026 1117544646 CMS
Amgen Inc. $12.04 07/23/2024 Food and Beverage Undisputed 01/23/2026 1117241917 CMS
Amgen Inc. $11.37 08/12/2024 Food and Beverage Undisputed 01/23/2026 1117544648 CMS
Amgen Inc. $15.97 09/19/2024 Food and Beverage Undisputed 01/23/2026 1117544650 CMS
Amgen Inc. $14.42 09/24/2024 Food and Beverage Undisputed 01/23/2026 1117241919 CMS
Amgen Inc. $13.49 10/29/2024 Food and Beverage Undisputed 01/23/2026 1117241921 CMS
Amgen Inc. $14.79 11/25/2024 Food and Beverage Undisputed 01/23/2026 1117241923 CMS
Ardelyx, Inc. $19.35 07/19/2024 Food and Beverage Undisputed 01/23/2026 1146724990 CMS
AstraZeneca Pharmaceuticals LP $130.58 03/28/2024 Food and Beverage Undisputed 01/23/2026 1105792136 CMS
AstraZeneca Pharmaceuticals LP $13.34 05/13/2024 Food and Beverage Undisputed 01/23/2026 1105868067 CMS
AstraZeneca Pharmaceuticals LP $124.99 09/17/2024 Food and Beverage Undisputed 01/23/2026 1104400815 CMS
Exact Sciences Corporation $15.38 06/10/2024 Food and Beverage Undisputed 01/23/2026 1114550625 CMS
Exact Sciences Corporation $13.08 12/14/2024 Food and Beverage Undisputed 01/23/2026 1114550621 CMS
Janssen Pharmaceuticals, Inc $14.77 03/25/2024 Food and Beverage Undisputed 01/23/2026 1078021920 CMS
Janssen Pharmaceuticals, Inc $13.38 05/12/2024 Food and Beverage Undisputed 01/23/2026 1078021910 CMS
Janssen Pharmaceuticals, Inc $15.05 07/26/2024 Food and Beverage Undisputed 01/23/2026 1078021902 CMS
Janssen Pharmaceuticals, Inc $15.05 09/10/2024 Food and Beverage Undisputed 01/23/2026 1078021970 CMS
Novo Nordisk Inc $12.17 02/13/2024 Food and Beverage Undisputed 01/23/2026 1100472441 CMS
Novo Nordisk Inc $8.13 03/11/2024 Food and Beverage Undisputed 01/23/2026 1100517865 CMS
Novo Nordisk Inc $7.92 04/08/2024 Food and Beverage Undisputed 01/23/2026 1100649465 CMS
Novo Nordisk Inc $11.23 05/20/2024 Food and Beverage Undisputed 01/23/2026 1100316254 CMS
Novo Nordisk Inc $6.61 06/02/2024 Food and Beverage Undisputed 01/23/2026 1100392782 CMS
Novo Nordisk Inc $11.09 08/05/2024 Food and Beverage Undisputed 01/23/2026 1100618826 CMS
Novo Nordisk Inc $16.14 08/19/2024 Food and Beverage Undisputed 01/23/2026 1100648515 CMS
Novo Nordisk Inc $16.87 09/09/2024 Food and Beverage Undisputed 01/23/2026 1100572556 CMS
Novo Nordisk Inc $10.78 09/23/2024 Food and Beverage Undisputed 01/23/2026 1100250626 CMS
Novo Nordisk Inc $12.44 11/04/2024 Food and Beverage Undisputed 01/23/2026 1100554439 CMS
Novo Nordisk Inc $18.33 11/18/2024 Food and Beverage Undisputed 01/23/2026 1100251782 CMS
Novo Nordisk Inc $10.27 12/02/2024 Food and Beverage Undisputed 01/23/2026 1100588145 CMS
PFIZER INC. $15.92 08/16/2024 Food and Beverage Undisputed 01/23/2026 1132039436 CMS
PFIZER INC. $14.75 10/11/2024 Food and Beverage Undisputed 01/23/2026 1132039374 CMS
PFIZER INC. $13.59 12/16/2024 Food and Beverage Undisputed 01/23/2026 1131134962 CMS
Sumitomo Pharma America, Inc. $13.97 09/16/2024 Food and Beverage Undisputed 01/23/2026 1148956782 CMS
Sumitomo Pharma America, Inc. $17.17 11/09/2024 Food and Beverage Undisputed 01/23/2026 1148956784 CMS
Takeda Pharmaceuticals U.S.A., Inc. $14.52 03/15/2024 Food and Beverage Undisputed 01/23/2026 1137736572 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2023, 2024
Source files
Dataset page · Bulk file · PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.